Cardiovascular safety of Glimepiride: An indirect comparison from CAROLINA and CARMELINA

BACKGROUND: Despite having unquestionable glucose lowering efficacy, current guidelines no more favour the uses of sulphonylureas for CV safety concern, except when cost is an issue. However, formal cardiovascular outcome trial (CVOT) is not available. MATERIALS AND METHODS: We performed an indirect...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghosh, Sujoy, Mukhopadhyay, Pradip, Pandey, Prabhakar, Chatterjee, Purushottam, Pandit, Kaushik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919221/
https://www.ncbi.nlm.nih.gov/pubmed/33213193
http://dx.doi.org/10.1177/1479164120973653

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919221/
https://www.ncbi.nlm.nih.gov/pubmed/33213193
http://dx.doi.org/10.1177/1479164120973653

Ejemplares similares